Table 3.
Univariate analysis of overall survival in patients with epithelial ovarian cancer
| Number | Estimate | Std. error | 95% Confidence interval | P (Log Rank, Mantel-Cox) | ||
|---|---|---|---|---|---|---|
| Lower bound | Upper bound | |||||
| Age | 0.572 | |||||
| ≤ 50 | 17 | 64.900 | 10.051 | 45.200 | 84.600 | |
| > 50 | 22 | 52.803 | 8.234 | 36.665 | 68.941 | |
| Chemotherapy sensitivity | 0.022 | |||||
| CR | 20 | 71.410 | 8.417 | 54.913 | 87.907 | |
| IR | 19 | 37.313 | 8.808 | 20.048 | 54.577 | |
| miR-206 expression | 0.043 | |||||
| Low | 20 | 74.923 | 11.042 | 53.280 | 96.566 | |
| High | 19 | 38.825 | 8.969 | 21.246 | 56.404 | |
| Subtype | 0.245 | |||||
| LGSC | 4 | 74.666 | 10.091 | 59.289 | 93.044 | |
| HGSC | 35 | 62.623 | 8.678 | 45.613 | 79.632 | |
| FIGO stage | 0.016 | |||||
| I | 2 | |||||
| II | 3 | 75.500 | 3.889 | 67.877 | 83.123 | |
| III | 32 | 56.921 | 7.655 | 41.917 | 71.925 | |
| IV | 2 | 12.500 | 8.500 | 0.000 | 29.160 | |
FIGO stage, International Federation of Gynecology and Obstetrics stage; HGSC, high grade serous carcinoma; LGSC, low grade serous carcinoma; CR, complete response; IR, incomplete response; P, P-value
The Ps set in italics considered statistically significant at < 0.05